240 related articles for article (PubMed ID: 30973897)
1. Inhibitors of signal peptide peptidase and subtilisin/kexin-isozyme 1 inhibit Ebola virus glycoprotein-driven cell entry by interfering with activity and cellular localization of endosomal cathepsins.
Plegge T; Spiegel M; Krüger N; Nehlmeier I; Winkler M; González Hernández M; Pöhlmann S
PLoS One; 2019; 14(4):e0214968. PubMed ID: 30973897
[TBL] [Abstract][Full Text] [Related]
2. Calu-3 cells are largely resistant to entry driven by filovirus glycoproteins and the entry defect can be rescued by directed expression of DC-SIGN or cathepsin L.
González-Hernández M; Müller A; Hoenen T; Hoffmann M; Pöhlmann S
Virology; 2019 Jun; 532():22-29. PubMed ID: 30999160
[TBL] [Abstract][Full Text] [Related]
3. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection.
Chandran K; Sullivan NJ; Felbor U; Whelan SP; Cunningham JM
Science; 2005 Jun; 308(5728):1643-5. PubMed ID: 15831716
[TBL] [Abstract][Full Text] [Related]
4. Cathepsin B & L are not required for ebola virus replication.
Marzi A; Reinheckel T; Feldmann H
PLoS Negl Trop Dis; 2012; 6(12):e1923. PubMed ID: 23236527
[TBL] [Abstract][Full Text] [Related]
5. Cathepsins B and L activate Ebola but not Marburg virus glycoproteins for efficient entry into cell lines and macrophages independent of TMPRSS2 expression.
Gnirss K; Kühl A; Karsten C; Glowacka I; Bertram S; Kaup F; Hofmann H; Pöhlmann S
Virology; 2012 Mar; 424(1):3-10. PubMed ID: 22222211
[TBL] [Abstract][Full Text] [Related]
6. Arbidol and Other Low-Molecular-Weight Drugs That Inhibit Lassa and Ebola Viruses.
Hulseberg CE; Fénéant L; Szymańska-de Wijs KM; Kessler NP; Nelson EA; Shoemaker CJ; Schmaljohn CS; Polyak SJ; White JM
J Virol; 2019 Apr; 93(8):. PubMed ID: 30700611
[TBL] [Abstract][Full Text] [Related]
7. A forward genetic strategy reveals destabilizing mutations in the Ebolavirus glycoprotein that alter its protease dependence during cell entry.
Wong AC; Sandesara RG; Mulherkar N; Whelan SP; Chandran K
J Virol; 2010 Jan; 84(1):163-75. PubMed ID: 19846533
[TBL] [Abstract][Full Text] [Related]
8. Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein.
Schornberg K; Matsuyama S; Kabsch K; Delos S; Bouton A; White J
J Virol; 2006 Apr; 80(8):4174-8. PubMed ID: 16571833
[TBL] [Abstract][Full Text] [Related]
9. Growth-Adaptive Mutations in the Ebola Virus Makona Glycoprotein Alter Different Steps in the Virus Entry Pathway.
Ruedas JB; Arnold CE; Palacios G; Connor JH
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021890
[TBL] [Abstract][Full Text] [Related]
10. Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivity.
Kaletsky RL; Simmons G; Bates P
J Virol; 2007 Dec; 81(24):13378-84. PubMed ID: 17928356
[TBL] [Abstract][Full Text] [Related]
11. Direct Visualization of Ebola Virus Fusion Triggering in the Endocytic Pathway.
Spence JS; Krause TB; Mittler E; Jangra RK; Chandran K
mBio; 2016 Feb; 7(1):e01857-15. PubMed ID: 26861015
[TBL] [Abstract][Full Text] [Related]
12. Ebola virus triggers receptor tyrosine kinase-dependent signaling to promote the delivery of viral particles to entry-conducive intracellular compartments.
Stewart CM; Phan A; Bo Y; LeBlond ND; Smith TKT; Laroche G; Giguère PM; Fullerton MD; Pelchat M; Kobasa D; Côté M
PLoS Pathog; 2021 Jan; 17(1):e1009275. PubMed ID: 33513206
[TBL] [Abstract][Full Text] [Related]
13. A Hyperstabilizing Mutation in the Base of the Ebola Virus Glycoprotein Acts at Multiple Steps To Abrogate Viral Entry.
Fels JM; Spence JS; Bortz RH; Bornholdt ZA; Chandran K
mBio; 2019 Jul; 10(4):. PubMed ID: 31289183
[TBL] [Abstract][Full Text] [Related]
14. A Glycoprotein Mutation That Emerged during the 2013-2016 Ebola Virus Epidemic Alters Proteolysis and Accelerates Membrane Fusion.
Fels JM; Bortz RH; Alkutkar T; Mittler E; Jangra RK; Spence JS; Chandran K
mBio; 2021 Feb; 12(1):. PubMed ID: 33593971
[TBL] [Abstract][Full Text] [Related]
15. Biochemical and structural characterization of cathepsin L-processed Ebola virus glycoprotein: implications for viral entry and immunogenicity.
Hood CL; Abraham J; Boyington JC; Leung K; Kwong PD; Nabel GJ
J Virol; 2010 Mar; 84(6):2972-82. PubMed ID: 20053739
[TBL] [Abstract][Full Text] [Related]
16. GILT restricts the cellular entry mediated by the envelope glycoproteins of SARS-CoV, Ebola virus and Lassa fever virus.
Chen D; Hou Z; Jiang D; Zheng M; Li G; Zhang Y; Li R; Lin H; Chang J; Zeng H; Guo JT; Zhao X
Emerg Microbes Infect; 2019; 8(1):1511-1523. PubMed ID: 31631785
[TBL] [Abstract][Full Text] [Related]
17. A Naturally Occurring Polymorphism in the Base of Sudan Virus Glycoprotein Decreases Glycoprotein Stability in a Species-Dependent Manner.
Lennemann NJ; Dillard J; Ruggio N; Cooney AL; Schaack GA; Davey RA; Maury W
J Virol; 2021 Aug; 95(18):e0107321. PubMed ID: 34232742
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Resistance of Ebola Virus Glycoprotein-Driven Entry Against MDL28170, An Inhibitor of Cysteine Cathepsins.
Hoffmann M; Kaufmann SV; Fischer C; Maurer W; Moldenhauer AS; Pöhlmann S
Pathogens; 2019 Oct; 8(4):. PubMed ID: 31618932
[TBL] [Abstract][Full Text] [Related]
19. A Polymorphism within the Internal Fusion Loop of the Ebola Virus Glycoprotein Modulates Host Cell Entry.
Hoffmann M; Crone L; Dietzel E; Paijo J; González-Hernández M; Nehlmeier I; Kalinke U; Becker S; Pöhlmann S
J Virol; 2017 May; 91(9):. PubMed ID: 28228590
[TBL] [Abstract][Full Text] [Related]
20. A Virion-Based Assay for Glycoprotein Thermostability Reveals Key Determinants of Filovirus Entry and Its Inhibition.
Bortz RH; Wong AC; Grodus MG; Recht HS; Pulanco MC; Lasso G; Anthony SJ; Mittler E; Jangra RK; Chandran K
J Virol; 2020 Aug; 94(18):. PubMed ID: 32611759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
